Monday 25 April 2022

Reuters Global Healthcare: Panic buying in Beijing stores amid COVID lockdown fears

Panic buying in Beijing stores amid COVID lockdown fears

A mass COVID-19 testing order in Beijing's biggest district prompted residents in the Chinese capital to stock up on groceries, fearing they could be destined for a lockdown similar to that of Shanghai.

Colombia to lift mask mandate for some indoor spaces from May 1

Colombia will lift a face mask mandate for some indoor spaces from May 1, President Ivan Duque said on Monday, though coverings will still be required on transport and in medical facilities and schools.

U.S. FDA approves Gilead's COVID-19 drug for young children

The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's drug remdesivir.

Britain to allow poultry outside as bird flu threat recedes

A mandatory housing order for poultry and captive birds in Britain is to be lifted, effective May 2, with the threat of bird flu now decreasing after the country's worst-ever outbreak.

China's Beijing city to expand mass COVID testing to more districts

Beijing will expand its mass COVID-19 testing campaign to another 10 districts and one economic development area from Tuesday to Saturday, an official for the Chinese capital said late on Monday.

Roche warns multiple sclerosis drug development hit by Ukraine war

Roche has warned that Russia's attack on Ukraine is disrupting the development of a new generation of multiple sclerosis (MS) drugs as the industry has come to disproportionately rely on Eastern Europe for clinical trials.

Valneva slumps after EU regulator requests more COVID vaccine data

French drugmaker Valneva said on Monday that the European Medicines Agency (EMA) had asked for more data on its COVID-19 vaccine, precipitating a sharp fall in its shares.

What you need to know about the coronavirus right now

Here's what you need to know about the pandemic right now:

Walgreens, Teva accused of fueling opioid addiction in quest for new markets

Walgreens Boots Alliance and Teva Pharmaceutical Industries Ltd ignored the health risks when they created new markets for opioids, a lawyer for the city of San Francisco told a judge on Monday during opening statements of the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.

Axsome expects U.S. FDA to decline approval for migraine drug, shares fall

Axsome Therapeutics said on Monday it expects the U.S. health regulator to decline approval for its treatment of acute migraine over unresolved issues of its quality control processes, sending shares of the drug developer down 20%.

Related Videos

Staff sleep at supermarket to keep Shanghai fed

Shanghai builds makeshift hospital amid COVID surge

Chicago Cubs fans return despite rising COVID cases

at